Nonaka D, et. al. Diffuse malignant mesothelioma of the peritoneum: a clinicopathological study of 35 patients treated locoregionally at a single institution. Cancer. 2005 Nov 15;104(10):2181-8.
Department of Pathology, National Cancer Institute, Milan, Italy. daisuke.nonaka@med.nyu.edu.
Dobra, Katalin. Malignant mesothelioma: an experimental study with emphasis on proteoglycans in mesothelial cell growth and differentiation. Karolinska Institutet, Huddinge University Hospital, Department of Immunologu, Microbiology, Pathology and Infectious Diseases, Stockholm, Sweden, 2002.
Trupiano, JK, Geisinger KR, Willingham MC, et. al.. Diffuse malignant mesothelioma of the peritoneum and pleura, analysis of markers. Mod. Pathol. 2004;17:476-481.
Rice MB, BCh, David C.. Staging of Malignany Plueral Mesothelioma: A Guideline for Patients. The University of Texas, M.D. Anderson Cancer Center
Rusch, MD, Valerie W., Venkatraman, PhD, E.. The Importance of Surgical Staging in the Treatment of Malignant Mesothelioma. J Thorac Cardiovasc Surg 1996; 111:815-826..
Butnor KJ, Sporn TA, Hammar SP, et. al. Well Differentiated Papillary Mesothelioma. Am J Surg Pathol 2001; 25(10): 1304-1309.
Mesothelioma Support Groups
Association of Cancer Online Resources (ACOR) manages a mailing list for mesothelioma patients.
Alliance for Lung Cancer, Advocacy, Support and Education Support Groups (ALCASE) national lung cancer support groups.
